1 of 4 listed pharmaceutical companies have ‘unsound’ financial structures

Published: 2016-03-15 10:40:03

Updated: 2016-03-15 10:40:03

1 of 4 listed pharmaceutical companies were indicated to have poor financial status with over 100% debt ratios.

In addition, Myungmoon Pharm and JW Shinyak exceeded 200% in the ratio while Sama Pharm was observed to have a single-digit debt ratio.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed pharmaceutical companies’ audit reports in 2015, their ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.